Reduced Fhit protein expression in nickel-transformed mouse cells and in nickel-induced murine sarcomas

Molecular and Cellular Biochemistry

Volumn 255, Issue 1-2, 2004, Pages 195-202

  Kowara, Renata ^a   Salnikow, Konstantin ^b   Diwan, Bhalchandra A ^c   Bare, Robert M ^a   Waalkes, Michael P ^a,d   Kasprzak, Kazimierz S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAIC FREDERICK INC   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Carcinogenesis; Fhit; Murine sarcomas; Nickel

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; MESSENGER RNA; METALLOTHIONEIN; NICKEL; PHOSPHATASE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; CARCINOGENESIS; CARCINOGENICITY; CELL CULTURE; CELL STRAIN; CELL TRANSFORMATION; DOWN REGULATION; ENZYME ACTIVITY; EPIGENETICS; FIBROSARCOMA; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; MALE; MALIGNANT TRANSFORMATION; MOUSE; MUTAGENICITY; NONHUMAN; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN METABOLISM; REVIEW; SARCOMA; TURNOVER TIME;

ACID ANHYDRIDE HYDROLASES; ANIMALS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; MICE; MICE, TRANSGENIC; MUSCLE NEOPLASMS; NEOPLASM PROTEINS; NICKEL; SARCOMA, EXPERIMENTAL;

ANIMALIA; MURINAE;

EID: 0742271932     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000007275.22785.91     Document Type: Review

References (39)

1. Huebner K, Garrison PN, Barnes LD, Croce CM: The role of the FHIT/FRA3B locus in cancer. Annu Rev Genet 32: 7-31, 1998
2. Croce C, Sozzi G, Huebner K: Role of FHIT in human cancer. J Clin Oncol 17: 1618-1624, 1999
3. Werner NS, Siprashvili Z, Fong LY, Marquitan G, Schroder JK, Bardenheuer W, Seeber S, Huebner K, Schutte J, Opalka B: Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression. Cancer Res 60: 2780-2785, 2000
4. Corbin S, Neilly ME, Espinosa R III, Davis EM, McKeithan W, Le Beau MM: FRA3B locus. Identification of unstable sequences within the common fragile site at 3p14.2: Implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors. Cancer Res 62: 3477-3484, 2002
5. 3-triphosphate hydrolase. Biochemistry 35: 11529-11535, 1996
6. Siprashvili Z, Sozzi G, Barnes L, McCue P, Robinson A, Eryomin V, Sard L, Tagliabue E, Greco A, Fusetti L, Schwatz G, Pierotti M, Croce C, Huebner K: Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci USA 94: 13771-13776, 1997
7. Chaudhuri AR, Khan IA, Prasad V, Robinson AK, Luduena RF, Barnes LD: The tumor suppressor protein Fhit. J Biol Chem 274: 24378-24382, 1999
8. Shi Y, Zou M, Farid NR, Paterson MC: Association of FHIT (fragile histidine triad), a candidate tumor suppressor gene, with the ubiquitin-conjugating enzyme hUBC9. Biochem J 352 Pt. 2: 443-448, 2000
9. Sard L, Accornero P, Tornielli S, Delia D, Bunone G, Campiglio M, Colombo MP, Gramegna M, Croce C, Pierotti MA, Sozzi G: The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc Natl Acad Sci USA 96: 8489-8492, 1999
10. Ji L, Fang B, Yen N, Fong K, Minna JD, Roth JA: Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad. Cancer Res 59: 3333-3339, 1999
11. Brenner C, Bieganowski P, Pace HC, Huebner K: The histidine triad superfamily of nucleotide-binding proteins. J Cell Physiol 181: 179-187, 1999
12. Kowara R, Karaczyn A, Fivash MJ, Kasprzak KS: In vitro inhibition of the enzymatic activity of tumor suppressor FHIT gene product by carcinogenic transition metals. Chem Res Toxicol 15: 319-325, 2002
13. Kasprzak KS: Possible role of oxidative damage in metal-induced carcinogenesis. Cancer Invest 13: 411-430, 1995
14. Wang XW, Imbra RJ, Costa M: Characterization of mouse cell lines resistant to nickel(II) ions. Cancer Res 48: 6850-6854, 1988
15. Klaassen CD, Liu J: Metallothionein transgenic and knock-out mouse models in the study of cadmium toxicity. J Toxicol Sci 23(suppl 2): 97-102, 1998
16. Waalkes MP, Diwan BA, Kasprzak KS: Metal carcinogenesis in MT+ and MT- mice. Toxicol Appl Pharmacol (in press)
17. Pekarsky Y, Druck T, Cotticelli MG, Ohta M, Shoo J, Mendrola J, Montgomery JC, Buchberg AM, Siracusa LD, Manenti G, Fong LY, Dragani TA, Croce CM, Huebner K: The routine Fhit locus: Isolation, characterization, and expression in normal and tumor cells. Cancer Res 58: 3401-3408, 1998
18. Palmiter RD, Sandgren EP, Koeller DM, Brinster RL: Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice. Mol Cell Biol 13: 5266-5275, 1993
19. Iszard MB, Liu J, Liu Y, Dalton T, Andrews GK, Palmiter RD, Klaassen CD: Characterization of metallothionein-I-transgenic mice. Toxicol Appl Pharmacol 133: 305-312, 1995
20. Pekarsky Y, Palamarchuk A, Huebner K, Croce CM: FHIT as tumor suppressor: Mechanisms and therapeutic opportunities. Cancer Biol Ther 1: 232-236, 2002
21. Dumon KR, Ishii H, Fong LY, Zanesi N, Fidanza V, Mancini R, Vecchione A, Baffa R, Trapasso F, During MJ, Huebner K, Croce CM: FHIT gene therapy prevents tumor development in Fhit-deficient mice. Proc Natl Acad Sci USA 98: 3346-3351, 2001
22. Yang Q, Yoshimura G, Suzuma T, Tamaki T, Umemura T, Nakamura M, Nakamura Y, Wang X, Mori I, Sakurai T, Kakudo K: Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma. Clin Cancer Res 7: 3869-3873, 2001
23. Pavelic K, Krizanac S, Cacev T, Hadzija MP, Radosevic S, Crnic I, Levanat S, Kapitanovic S: Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas. Mol Med 7: 442-453, 2001
24. Morikawa H, Nakagawa Y, Hashimoto K, Niki M, Egashira Y, Hirata I, Katsu K, Akao Y: Frequent altered expression of fragile histidine triad protein in human colorectal adenomas. Biochem Biophys Res Commun 278: 205-210, 2000
25. Kitamura A, Yashima K, Okamoto E, Andachi H, Hosoda A, Kishimoto Y, Shiota G, Ito H, Kaibara N, Kawasaki H: Reduced Fhit expression occurs in the early stage of esophageal tumorigenesis: No correlation with p53 expression and apoptosis. Oncology 61: 205-211, 2001
26. Vasak M, Hasler DW: Metallothioneins: New functional and structural insights. Curr Opin Chem Biol 4: 177-183, 2000
27. Shimoda R, Nagamine T, Takagi H, Mori M, Waalkes MP: Induction of apoptosis in cells by cadmium: Quantitative negative correlation between basal or induced metallothionein concentration and apoptotic rate. Toxicol Sci 64: 208-215, 2001
28. Lima CD, D'Amico KL, Naday I, Rosenbaum G, Westbrook EM, Hendrickson WA: MAD analysis of FHIT, a putative human tumor suppressor from the HIT protein family. Structure 5: 763-774, 1997
29. Pace HC, Garrison PN, Robinson AK, Barnes LD, Draganescu A, Rosler A, Blackburn GM, Siprashvili Z, Croce CM, Huebner K, Brenner C: Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit. Proc Natl Acad Sci USA 95: 5484-5489, 1998
30. Kuehn K, Sunderman FW Jr: Dissolution half-times of nickel compounds in water, rat serum, and renal cytosol. J Inorg Biochem 17: 29-39, 1982
31. Kasprzak KS: Oxidative DNA damage in metal-induced carcinogenesis. In: L.W. Chang (ed). Toxicology of Metals. CRC Lewis Publishers, Boca Raton, FL, 1996, pp 299-320
32. Kasprzak KS: Oxidative DNA and protein damage in metal-induced toxicity and carcinogenesis. Free Radic Biol Med 32: 958-967, 2002
33. Bauman JW, Liu J, Klaassen CD: Production of metallothionein and heat-shock proteins in response to metals. Fundam Appl Toxicol 21: 15-22, 1993
34. Jourdan E, Emonet-Piccardi N, Didier C, Beani JC, Favier A, Richard MJ: Effects of cadmium and zinc on solar-simulated light-irradiated cells: Potential role of zinc-metallothionein in zinc-induced geno-protection. Arch Biochem Biophys 405: 170-177, 2002
35. Chimienti F, Jourdan E, Favier A, Seve M: Zinc resistance impairs sensitivity to oxidative stress in HeLa cells: Protection through metallothioneins expression. Free Radic Biol Med 31: 1179-1190, 2001
36. Bourdon E, Blache D: The importance of proteins in defense against oxidation. Antioxid Redox Signal 3: 293-311, 2001
37. Kasprzak KS, Hernandez L: Enhancement of hydroxylation and deglycosylation of 2′-deoxyguanosine by carcinogenic nickel compounds. Cancer Res 49: 5964-5968, 1989
38. Kasai H, Nishimura S: Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res 12: 2137-2145, 1984
39. Sunderman FW Jr: Carcinogenicity of nickel compounds in animals. In: IARC Scientific Publications, No. 53. Nickel in the Human Environment. IARC, Lyon, 1984, pp 127-142